0 التعليقات
0 المشاركات
2كيلو بايت مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Enterprise Network Firewall Market Growth: Latest Trends, Demand Analysis & ForecastAcumen Research and Consulting (ARC) is a leading provider of The global market for Enterprise Network Firewall Market is experiencing dynamic shifts, driven by several factors such, changing consumer preferences, and increasing global competition. This report is based on recent analysis, and forecasts of key industries as studied and analyzed by Acumen Research and Consulting. It...0 التعليقات 0 المشاركات 388 مشاهدة 0 معاينة
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Oncology Drugs Market to Reach USD 503.13 Billion by 2033, Growing at 11.6% CAGRMarket Overview The global oncology drugs market size was valued at USD 193.04 billion in 2024 and is projected to grow from USD 209.57 billion in 2025 to USD 503.13 billion by 2033, exhibiting a CAGR of 11.6% during the forecast period (2025-2033). The global Oncology Drugs market is witnessing swift transformation driven by new consumer behaviors, increased...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة